Other languages Insmed Incorporated

Equities

INSM

US4576693075

Real-time Estimate Cboe BZX Other stock markets 02:19:42 2024-06-26 pm EDT			5-day change	1st Jan Change
68.86 ^USD	-1.23%		+5.61%	+120.52%

Jun. 21	Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating	MT
Jun. 20	JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Insmed Insider Sold Shares Worth $1,271,700, According to a Recent SEC Filing	Jun. 12
Insmed Insider Sold Shares Worth $3,043,150, According to a Recent SEC Filing	Jun. 05
Insmed Insider Sold Shares Worth $1,362,075, According to a Recent SEC Filing	May. 31
Insmed Insider Sold Shares Worth $12,064,607, According to a Recent SEC Filing	May. 31
Insmed Insider Sold Shares Worth $6,316,579, According to a Recent SEC Filing	May. 31
Insmed Insider Sold Shares Worth $2,215,081, According to a Recent SEC Filing	May. 31
Insmed Prices $650 Million Public Offering	May. 30
Insmed Plans $500 Million Public Offering	May. 29
Sector Update: Health Care Stocks Fall Late Afternoon	May. 28
Sector Update: Health Care	May. 28
Top Midday Gainers	May. 28
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	May. 28
Sector Update: Health Care	May. 28
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Earnings Season Wanes	May. 28
Top Premarket Gainers	May. 28
Insmed's Lung Disease Drug Meets Primary Endpoint in Late-Stage Study -- Shares Surge Premarket	May. 28
Insmed's lung disease drug succeeds in late-stage study	May. 28
Insmed Incorporated Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis	May. 28
Insmed Lung Infections Treatment Study Shows Improvement	May. 20
Insmed Incorporated Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 Arise Study of Arikayce in Patients with NTM Lung Disease at American Thoracic Society 2024 International Conference Plenary Session	May. 20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Insmed Incorporated

Equities

INSM

US4576693075

Other languages

Filters